posted on 2021-11-11, 16:27authored byYongfu Yu, Melissa Soohoo, Henrik Toft Sørensen, Jiong Li, Onyebuchi A. Arah
<b>OBJECTIVE</b>
<p>To evaluate
associations between gestational diabetes mellitus (GDM) and various incident
cardiovascular disease (CVD) endpoints, considering the effects of mediating
role of type 2 diabetes and shared environmental/familial
factors.</p>
<p><b>RESEARCH DESIGN AND METHODS</b></p>
<p>This
population-based cohort study included 1002486 parous women in Denmark during
1978-2016. We used Cox regression to (i) examine the associations of GDM with overall
and type-specific CVDs using full-cohort and sibling-matched analysis; (ii)
quantify the impact of type 2 diabetes after GDM
using mediation analysis; and (iii) assess whether these associations were modified
by pre-pregnancy obesity or maternal history of CVD.</p>
<p><b>RESULTS</b></p>
<p>Women with a history of GDM had a 40% increased overall CVD risk (hazard
ratio [HR]: 1.40, 95% confidence
interval [CI]: 1.35-1.45). Sibling-matched analyses yielded
similar results(HR, 1.44; 95%CI, 1.28-1.62). Proportion of association between GDM and overall CVD explained
by subsequent type 2 diabetes was 23.3%(15.4%-32.8%).
We observed increased risks of specific CVDs, including
65% increased stroke risk and more than two-fold risks for myocardial
infarction, heart failure, and peripheral artery disease. The elevated overall risks were more
pronounced among women with GDM and pre-pregnancy obesity or maternal history of CVD. </p>
<p><b>CONCLUSIONS</b></p>
<p>A history of GDM was associated with increased risks
of overall and specific CVDs. Increased risks were partly explained by
subsequent type 2 diabetes and the need to identify
other pathways remains important. Continuous monitoring of women with a history
of GDM, especially those with pre-pregnancy obesity or maternal history of CVD,
may provide better opportunities to reduce their cardiovascular risk.</p>
Funding
This study was supported by unrestricted grants from the Independent Research Fund Denmark (DFF-6110-00019B, DFF 9039-00010B and DFF-1030-00012B); grants from the Nordic Cancer Union (R275-A15770); a grant from the Karen Elise Jensens Fond (2016); a grant from the Novo Nordisk Foundation (NNF18OC0052029), a grant from Shanghai Rising-Star Program (21QA1401300), a grant from the National Natural Science Foundation of China (No. 82073570), a grant from an NIH grant (UL1TR001881) from the National Center for Advancing Translational Science, and the facilities and resources provided by the California Center for Population Research at UCLA (CCPR) which receives core support (grant R24HD041022) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health.